Study Shows Two-Year Clinical Benefits for Kidney Disease Risk Test
A two-year real-world study of Renalytix’s FDA-approved KidneyIntelX.dkd test showed improved kidney function and targeted treatment in 2,470 patients with type 2 diabetes.
A two-year real-world study of Renalytix’s FDA-approved KidneyIntelX.dkd test showed improved kidney function and targeted treatment in 2,470 patients with type 2 diabetes.
Quest Diagnostics will acquire select assets of Fresenius Medical Care's Spectra Laboratories, expanding its capabilities.
The NIST released new standard reference material that uses urine to check for kidney disease and conditions that affect kidney function.
The AACC, in collaboration with the NKF, has released guidance to reduce racial and gender disparities in the care of chronic kidney disease.
Read MoreScreening all adults in the United States for CKD starting at age 35 could be cost effective for the quality of life-years gained.
Read MoreHealthy.io is launching a program with Boehringer Ingelheim that will support at-home testing for patients at risk of chronic kidney disease.
Read MoreA new proteomic risk model for cardiovascular disease was found to be more accurate than current methods of measuring cardiac risk
Read MoreResearchers found that higher levels of certain biomarkers in urine and blood can predict a patient’s risk of chronic kidney disease.
Read MoreNatera detailed a paper highlighting the clinical utility of its comprehensive kidney gene panel Renasight in aiding kidney disease diagnosis.
Read MoreBroad-based genetic testing gives clinicians better insights into chronic kidney disease, improving the odds of a good transplant outcome.
Read MoreA personalized approach to kidney disease screening for type 1 diabetes patients may reduce the time chronic kidney disease goes undetected.
Read MoreA team of researchers identified a new technique that can detect damage to children’s kidneys earlier than current tests
Read MoreAcute kidney injury is common in patients in the ICU. Predicting which patients are at risk helps clinicians take preventive measures.
Read MoreResearch shows that removing a race modifier from a formula used to diagnose kidney disease may lead to equitable care for Black patients.
Read MoreMillions of COVID patients may have undiagnosed acute kidney injury, a condition where the kidneys fail to filter waste from the blood.
Read MoreResearchers established the inherited condition, TULP3-related ciliopathy, which causes kidney and liver failure in children and adults.
Read MoreIn 2010, scientists discovered that African Americans born with a certain gene have a higher risk for experiencing chronic kidney disease.
Read MoreNova Biomedical’s tool improves kidney care through improved kidney function screening and early kidney disease detection.
Read More